Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

The US labor market has weakened since March 2025, and it's likely to continue weakening based on the policies in place, ...

Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...

This normalization of mobile finance has important implications. Users are not experimenting with FinTech platforms on the ...

Kazuo Ueda, the Bank of Japan Governor, plans to keep hiking interest rates. The BOJ's next move depends on the economic ...

Much like the space race of 60-70 years ago, the winners of this arms race will establish all new power and influence on the ...

The rapid normalization of AI risks creating new forms of atypical digital companionship at a time when societies are still ...

While the ambition was sound, the technology and market structure of 20 years ago simply weren’t ready. Today, that same ...

As 2026 begins, the industry must rethink value, prioritize human service, address ethical challenges, and adapt to shifting ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...